Global Anticancer Drug Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Anticancer Drug market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Anticancer Drug market."
Anticancer Drugs are used to treat malignancies, or cancerous growths. Drug therapy may be used alone, or in combination with other treatments such as surgery or radiation therapy.
Anticancer drugs are agents that demonstrate activity against malignant disease. They include alkylating agents, antimetabolites, natural products, and hormones, as well as a variety of other chemicals that do not fall within these discrete classes but are capable of preventing the replication of cancer cells and thus are used in the treatment of cancer.

The global Anticancer Drug market is valued at 98300 million US$ in 2018 is expected to reach 165100 million US$ by the end of 2025, growing at a CAGR of 6.7% during 2019-2025.
This report focuses on Anticancer Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anticancer Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Roche
    Celgene
    Pfizer
    Bristol-Myers Squibb
    Novartis
    AstraZeneca
    Teva Pharmaceuticals
    Bayer
    GlaxoSmithKline

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Targeted Drugs
    Cytotoxic Drugs
    Hormonal Drugs

Segment by Application
    Immunotherapy
    Targeted Therapy
    Chemotherapy
    Hormonal Therapy
    Others